.jpg)
.png)
Potpourri 2015
This issue sponsored by the National Lipid Association Featuring: “The Impact of Gilbert's Syndrome on Atherosclerosis” and "Dyslipidemia, Cardiovascular Disease, and Youth with Diabetes" more
Patients with chronic kidney disease (CKD) including those undergoing dialysis have an increased risk of premature cardiovascular disease (CVD).1 CKD patients also have a high rate of coronary death and myocardial infarction — rates equivalent to those of diabetics. CKD, per se, has thus been... more
The National Lipid Association (NLA) is proud to move forward with its Recommendations for Patient-Centered Management of Dyslipidemia for those practicing clinical lipidology in an environment where many clinical queries remain unanswered for clinicians. To that end, the NLA has developed Part II... more
The greater danger for most of us lies not in setting our aim too high and falling short; but in setting our aim too low, and achieving our mark.” Michelangelo Buonarroti Along with the NLA Scientific Sessions, the summer also brings the anticipation of the Prescription Drug User Fee Act (... more
Although low-density lipoprotein cholesterol (LDL-C) lowering with statin therapy has been part of the National Cholesterol Education Program guidelines for 26 years, significant residual cardiovascular risk remains in both primary- and secondary-prevention patients. This residual risk is... more
Lifestyle-related risk factors can prevent or promote atherosclerotic cardiovascular disease (ASCVD). Thus, management of lifestyle factors is crucial in addressing the burden of ASCVD. Nonetheless, addressing these factors has often been overshadowed by the administration of medications. Over the... more
A 51-year-old female with a history of premature coronary heart disease and coronary artery bypass grafting at age 36 was referred for hyperlipidemia. She had untreated low-density lipoprotein cholesterol (LDL-C) >600 mg/dL, a previous cholecystectomy, and non-alcoholic fatty liver. On maximal... more
Introduction Individuals with diabetes have an increased risk of morbidity and mortality related to cardiovascular disease,1 accounting for 44 percent of deaths in patients with type 1 diabetes mellitus and 57 percent of deaths in patients with type 2 diabetes mellitus.2 Although youth with... more
Introduction The development and use of antiretroviral medications to treat patients infected with HIV have dramatically changed the course of this disease from one that was fatal to a chronic and more manageable condition. However, with antiretroviral therapy (ART) came a new spectrum of... more
After the clinical studies, Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes (AIM-HIGH) and Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE), the National Lipid Association... more